Adaptable manufacturing platforms enable in vivo mRNA-LNP delivery, says Lonza
By
Søren Hough
1mo agoen
Source
bioprocessintl.comAdaptable manufacturing platforms enable in vivo mRNA-LNP delivery, says Lonzabioprocessintl.comManufacturing expert Telmo Graça believes a more agile CMC process will reduce costs and bring drugs to market faster.
You might also wanna read

Magnetic mixer improves 3D bioprinting
MIT·4mo ago

Tecnologia impulsiona integração no varejo farmacêutico
Extra Online·1d ago

Fortalecen la logística de medicamentos con un sistema digital de trazabilidad
Infobae·2d ago
Study Shows Low-Cost Portable Biotech Tools Can Expand Access to Research and Diagnostics in Resource-Limited Settings
A global research team led by University of Toronto's Leslie Dan Faculty of Pharmacy has demonstrated the effectiveness of low-cost, portabl
Extropic presents first pharmaceutical application for thermodynamic computing hardware with codon optimization
This paper from Extropic Corp. presents the first concrete pharmaceutical application mapped to thermodynamic hardware, focusing on energy-e
docs.thrml.ai·19d ago
How LLMs Are Transforming Preclinical Drug Discovery Data Access
The article discusses how Large Language Models (LLMs) are being applied to preclinical drug discovery to help researchers efficiently acces
martinfowler.com·17d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.